Cardionovum

Be up
to date.

Latest press release

On June 8th, in Sankt Gertrauden hospital in Berlin, Germany, the first Signature RCT patient has been enrolled

Trial designed to evaluate non inferiority of XLIMUS DES vs SYNERGY EES in terms of reendothelialization assessed with OCT in patients undergoing percutaneous coronary intervention

Marc Bosiers (St. Blasius Hospital, Dendermonde, Belgium) will give an update at LINC today on the results of the REFLOW1 study, which investigated the efficacy of the LEGFLOW® drug-coated balloon (DCB) in TASC C and D femoropopliteal lesions.

Professor Dr Qizhuang Jin (Peking University First Hospital Nephrology Department, China) spoke to LINC Today about the recently published results of the first randomised controlled trial (RCT) comparing the APERTO® drug-coated balloon (DCB) with high pressure angioplasty balloon in the treatment of arteriovenous fistulae (AVF) lesions.

In a Q&A with LINC Today, Michael Lichtenberg, angiologist at Klinikum Hochsauerland GmbH, Arnsberg, Germany, discussed the APERTO® OTW (over-the-wire) drug coated balloon (DCB) currently being trialled in haemodialysis patients with central venous stenosis (CVS) in a bid to improve patency of arteriovenous fistulas (AVFs).

Guest from Europe: Prof. Michael Lichtenberg (Germany) & Prof. Matteo Tozzi (Italy).

Video of European guests' speech.

Upcoming events

Currently there are no events.

Latest events

Cardionovum at LINC

Cardionovum participates at LINC Leipzig Interventional Course

Date: Jan 24, 2017–Jan 27, 2017

Location: Leipzig, Germany

Learn more >>

Visit website >>

Cardionovum at CIRSE

Cardionovum participates at CIRSE

Date: Sep 09, 2016–Sep 13, 2016

Location: Barcelona, Spain

Visit website >>

Cardionovum at EuroPCR

Cardionovum participates at EuroPCR

Date: May 16, 2016–May 19, 2016

Location: Paris, France

Visit website >>

go top